TY  - JOUR 
AU  - Morel, Pierre
AU  - Duhamel, Alain
AU  - Gobbi, Paolo
AU  - Dimopoulos, Meletios A.
AU  - Dhodapkar, Madhav V.
AU  - McCoy, Jason
AU  - Crowley, John
AU  - Ocio San Miguel, Enrique M.
AU  - García Sanz, Ramón
AU  - Treon, Steven P.
AU  - Leblond, Veronique
AU  - Kyle, Robert A.
AU  - Barlogie, Bart
AU  - Merlini, Giampaolo
PY  - 2009
SN  - 0006-4971
UR  - http://hdl.handle.net/10366/155235
AB  - [EN]Recently, many new drugs have been developed for the treatment of Waldenström macroglobulinemia (WM). To optimize the treatment according to the prognosis and to facilitate the comparison of trials, we developed an International Prognostic Scoring...
LA  - eng
PB  - American Society of Hematology
KW  - Waldenstrom macroglobuliemia
KW  - Prognosis
KW  - Survival
KW  - International Classification
KW  - Prognosis
KW  - Aged
KW  - Validation Studies as Topic
KW  - Treatment Outcome
KW  - Humans
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Survival Rate
KW  - Waldenstrom Macroglobulinemia
TI  - International prognostic scoring system for Waldenstrom macroglobulinemia
DO  - 10.1182/blood-2008-08-174961
T2  - Blood
VL  - 113
M2  - 4163
ER  -